55P Clinicopathological and molecular changes induced by neoadjuvant therapy (NAT) in hormone receptor-positive (HR+)/HER2-low vs HER2 0 breast cancer (BC)
| Autor: | Schettini, F., Pascual, T., Ghiglione, L., Brasó-Maristany, F., Martínez-Sáez, O., Conte, B., Cebrecos, I., Mension, E., Ganau, S., Torres, E. Sanfeliu, Gonzalez-Farre, B., Jares, P., Vidal-Siscart, S., Mollá, M., Adamo, B., Losada, M.J. Vidal, Munoz, M., Prat, A. |
|---|---|
| Zdroj: | In ESMO Open May 2023 8(1) Supplement 4 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|